Study identifier:BY9010/M1-205
ClinicalTrials.gov identifier:NCT00163410
EudraCT identifier:N/A
CTIS identifier:N/A
A comparative study of inhaled ciclesonide 200 mcg/day vs fluticasone propionate 200 mcg/day in children with asthma
asthma
Phase 3
No
Ciclesonide
All
500
Interventional
4 Years - 15 Years
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment
Verified 01 Dec 2016 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|